MEPOLIZUMAB

MEPOLIZUMAB was reported 50431 times

MEPOLIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLETHYSMOGRAPHY 25 0.9615
1 TOTAL LUNG CAPACITY INCREASED 187 0.6875
2 SPUTUM CULTURE 25 0.6757
3 HEART SOUNDS 63 0.6562
4 AIRWAY REMODELLING 69 0.5565
5 HEPATIC ENZYME 80 0.5369
6 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 261 0.4990
7 REVERSIBLE AIRWAYS OBSTRUCTION 226 0.4449
8 VITAL CAPACITY DECREASED 184 0.4107
9 TOTAL LUNG CAPACITY ABNORMAL 153 0.3933
10 HYPOCHOLESTEROLAEMIA 138 0.3909
11 PROLONGED EXPIRATION 100 0.3817
12 PULMONARY VASCULITIS 189 0.3513
13 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 688 0.3371
14 EOSINOPHIL COUNT ABNORMAL 232 0.3106
15 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 271 0.2923
16 SPIROMETRY ABNORMAL 173 0.2893
17 CENTRAL NERVOUS SYSTEM MASS 27 0.2842
18 EOSINOPHILIC BRONCHITIS 56 0.2800
19 ANTACID THERAPY 36 0.2769
20 CAPILLARITIS 72 0.2609
21 MITE ALLERGY 164 0.2504
22 WALL MOTION SCORE INDEX ABNORMAL 27 0.2455
23 LUNG DIFFUSION DISORDER 38 0.2420
24 FUNGAL DISEASE CARRIER 24 0.2376
25 FACET JOINT SYNDROME 773 0.2372
26 ACQUIRED FACTOR V DEFICIENCY 26 0.2364
27 COAGULATION FACTOR V LEVEL ABNORMAL 29 0.2358
28 RESPIRATORY GAS EXCHANGE DISORDER 79 0.2129
29 NASAL POLYPECTOMY 33 0.2075
30 CONGENITAL HIATUS HERNIA 47 0.2061
31 OBSTRUCTIVE AIRWAYS DISORDER 2203 0.1978
32 VOCAL CORD DYSFUNCTION 97 0.1968
33 PULMONARY FUNCTION TEST ABNORMAL 299 0.1918
34 MALIGNANT MELANOMA STAGE 0 40 0.1914
35 BRONCHIAL WALL THICKENING 136 0.1892
36 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3148 0.1852
37 COAGULATION FACTOR DEFICIENCY 29 0.1801
38 PERIPHERAL VENOUS DISEASE 733 0.1793
39 MYCOTIC ALLERGY 152 0.1778
40 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 130 0.1774
41 FULL BLOOD COUNT ABNORMAL 1871 0.1767
42 LARYNGEAL STENOSIS 102 0.1765
43 ATOPY 49 0.1763
44 OVERLAP SYNDROME 123 0.1757
45 NASAL POLYPS 852 0.1729
46 BRONCHIAL SECRETION RETENTION 220 0.1727
47 SLEEP DISORDER THERAPY 34 0.1717
48 ASTHMATIC CRISIS 618 0.1690
49 DUST ALLERGY 164 0.1672
50 FORCED EXPIRATORY VOLUME ABNORMAL 24 0.1655
51 PARATHYROID GLAND ENLARGEMENT 23 0.1608
52 ONYCHOMADESIS 672 0.1600
53 SPUTUM PURULENT 105 0.1596
54 RESPIRATORY SYMPTOM 432 0.1517
55 QUARANTINE 30 0.1463
56 FACTOR V LEIDEN MUTATION 58 0.1461
57 PATIENT ISOLATION 31 0.1442
58 MYCOBACTERIUM TEST POSITIVE 29 0.1408
59 BRONCHIAL OBSTRUCTION 196 0.1395
60 SPUTUM CULTURE POSITIVE 112 0.1379
61 BLOOD IMMUNOGLOBULIN E INCREASED 316 0.1304
62 BLEPHAROSPASM 813 0.1290
63 ANTICOAGULANT THERAPY 36 0.1268
64 LYMPH NODE CALCIFICATION 24 0.1237
65 ASTHMA EXERCISE INDUCED 43 0.1236
66 RHEUMATIC FEVER 546 0.1224
67 NEURITIS 189 0.1223
68 WHEEZING 7204 0.1214
69 UPPER RESPIRATORY FUNGAL INFECTION 23 0.1211
70 EOSINOPHILIC PNEUMONIA CHRONIC 35 0.1178
71 LUNG HYPERINFLATION 101 0.1174
72 SPUTUM DISCOLOURED 1109 0.1168
73 BREAST CANCER STAGE III 756 0.1166
74 CONJUNCTIVITIS ALLERGIC 169 0.1140
75 ASTHMA 12892 0.1139
76 SWOLLEN JOINT COUNT 28 0.1120
77 CHRONIC SINUSITIS 420 0.1118
78 ONYCHOMYCOSIS 490 0.1116
79 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 793 0.1106
80 HYPEREOSINOPHILIC SYNDROME 59 0.1091
81 ANALGESIC THERAPY 35 0.1090
82 FORCED EXPIRATORY VOLUME DECREASED 307 0.1083
83 VAGINAL FLATULENCE 32 0.1056
84 PEAK EXPIRATORY FLOW RATE DECREASED 46 0.1045
85 EOSINOPHIL COUNT INCREASED 865 0.1037
86 DRUG THERAPY 35 0.1032
87 BREATH SOUNDS ABNORMAL 509 0.1031
88 RHINITIS ALLERGIC 457 0.1026
89 LUNG DIFFUSION TEST DECREASED 40 0.1003
90 TOTAL LUNG CAPACITY DECREASED 159 0.0995
91 BACTERIAL DISEASE CARRIER 71 0.0974
92 DUODENAL ULCER PERFORATION 715 0.0961
93 LUPUS VULGARIS 119 0.0944
94 BRONCHIECTASIS 621 0.0921
95 MUSCLE INJURY 753 0.0908
96 FOLLICULITIS 951 0.0906
97 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4281 0.0890
98 BLOOD COUNT ABNORMAL 1343 0.0885
99 DISLOCATION OF VERTEBRA 202 0.0885
100 RESTRICTIVE PULMONARY DISEASE 103 0.0879
101 RESPIRATORY TRACT INFLAMMATION 40 0.0858
102 CHEST X-RAY ABNORMAL 260 0.0847
103 CORONAVIRUS TEST POSITIVE 87 0.0845
104 HYPERCHOLESTEROLAEMIA 813 0.0841
105 INSPIRATORY CAPACITY DECREASED 23 0.0830
106 VENOUS PRESSURE JUGULAR INCREASED 30 0.0826
107 SINONASAL OBSTRUCTION 32 0.0796
108 NSAID EXACERBATED RESPIRATORY DISEASE 30 0.0794
109 FORCED VITAL CAPACITY DECREASED 51 0.0781
110 LIP DRY 702 0.0772
111 BRONCHIAL HYPERREACTIVITY 92 0.0765
112 FINGER DEFORMITY 369 0.0761
113 NAIL DISORDER 658 0.0751
114 UPPER-AIRWAY COUGH SYNDROME 612 0.0742
115 INFUSION SITE REACTION 221 0.0739
116 HELICOBACTER INFECTION 744 0.0723
117 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5092 0.0715
118 PRODUCT COMPLAINT 1810 0.0714
119 C-REACTIVE PROTEIN ABNORMAL 456 0.0710
120 SPUTUM ABNORMAL 47 0.0709
121 BURSITIS 847 0.0697
122 EAR PRURITUS 244 0.0695
123 PEMPHIGUS 869 0.0694
124 SPUTUM RETENTION 66 0.0666
125 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 37 0.0660
126 WOUND INFECTION 700 0.0639
127 LUNG OPACITY 168 0.0637
128 EXPOSURE VIA SKIN CONTACT 1614 0.0622
129 RETINITIS 107 0.0619
130 BACK INJURY 663 0.0609
131 USE OF ACCESSORY RESPIRATORY MUSCLES 25 0.0605
132 ASPIRIN-EXACERBATED RESPIRATORY DISEASE 37 0.0602
133 DEEP VEIN THROMBOSIS POSTOPERATIVE 120 0.0599
134 JOINT RANGE OF MOTION DECREASED 797 0.0594
135 OBESITY 924 0.0579
136 HAND DEFORMITY 746 0.0568
137 LIVE BIRTH 471 0.0562
138 SINUS OPERATION 134 0.0562
139 STATUS ASTHMATICUS 26 0.0551
140 RALES 311 0.0535
141 PNEUMOCOCCAL INFECTION 31 0.0524
142 INCREASED BRONCHIAL SECRETION 134 0.0523
143 SINUS POLYP 30 0.0520
144 X-RAY ABNORMAL 93 0.0520
145 MONONEUROPATHY MULTIPLEX 24 0.0519
146 INCREASED VISCOSITY OF BRONCHIAL SECRETION 33 0.0517
147 NASAL DISCHARGE DISCOLOURATION 71 0.0514
148 SYNOVITIS 919 0.0509
149 MULTIPLE ALLERGIES 399 0.0508
150 PERICARDITIS 853 0.0507
151 PRODUCT LABEL CONFUSION 295 0.0506
152 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 104 0.0501
153 PRODUCTIVE COUGH 2358 0.0493
154 NORMOCHROMIC NORMOCYTIC ANAEMIA 145 0.0482
155 EOSINOPHIL COUNT DECREASED 114 0.0478
156 MYCOBACTERIAL INFECTION 82 0.0476
157 GRIP STRENGTH DECREASED 416 0.0472
158 SPUTUM INCREASED 102 0.0471
159 HAEMOPHILUS INFECTION 46 0.0469
160 VASCULITIS 529 0.0454
161 DYSPNOEA PAROXYSMAL NOCTURNAL 33 0.0453
162 MUCOSAL DISCOLOURATION 29 0.0452
163 SUPERINFECTION 66 0.0440
164 EOSINOPHILIC MYOCARDITIS 32 0.0438
165 SWOLLEN JOINT COUNT INCREASED 139 0.0435
166 PRECANCEROUS CONDITION 29 0.0433
167 C-REACTIVE PROTEIN 40 0.0431
168 SARCOIDOSIS 201 0.0423
169 GLOSSODYNIA 941 0.0420
170 EOSINOPHILIA 728 0.0415
171 PORPHYRIA ACUTE 59 0.0411
172 IRRITABLE BOWEL SYNDROME 856 0.0399
173 VITAL FUNCTIONS ABNORMAL 34 0.0397
174 UPPER AIRWAY OBSTRUCTION 35 0.0395
175 KYPHOSIS 69 0.0390
176 SINUSITIS FUNGAL 31 0.0387
177 NOCTURNAL DYSPNOEA 49 0.0384
178 BLOOD LACTIC ACID INCREASED 201 0.0381
179 RHINITIS 304 0.0377
180 CARDIAC SEPTAL DEFECT 27 0.0376
181 LOWER RESPIRATORY TRACT INFECTION 1709 0.0375
182 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 25 0.0374
183 LUNG DISORDER 1799 0.0367
184 PLEURITIC PAIN 101 0.0366
185 TASTE DISORDER 734 0.0361
186 RHONCHI 49 0.0355
187 PULMONARY FUNCTION TEST DECREASED 155 0.0354
188 NASAL DISORDER 94 0.0353
189 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1645 0.0352
190 CONGENITAL ANOMALY 272 0.0351
191 PULMONARY ALVEOLAR HAEMORRHAGE 196 0.0349
192 WOUND 974 0.0348
193 BRONCHIAL DISORDER 54 0.0347
194 CREPITATIONS 103 0.0346
195 SOCIAL PROBLEM 142 0.0343
196 BONE EROSION 121 0.0342
197 STEROID DEPENDENCE 29 0.0330
198 DYSPNOEA EXERTIONAL 1240 0.0329
199 PULMONARY MASS 490 0.0329
200 NEUROLOGICAL SYMPTOM 188 0.0329
201 COELIAC DISEASE 321 0.0327
202 FIBROMYALGIA 795 0.0327
203 SENSE OF OPPRESSION 38 0.0323
204 SECRETION DISCHARGE 398 0.0317
205 JAUNDICE CHOLESTATIC 111 0.0314
206 CENTRAL OBESITY 23 0.0311
207 MICROANGIOPATHY 29 0.0309
208 NASAL OBSTRUCTION 57 0.0304
209 BLOOD TEST ABNORMAL 422 0.0300
210 BLOOD ALKALINE PHOSPHATASE ABNORMAL 27 0.0300
211 SINUS PAIN 70 0.0300
212 RESPIRATION ABNORMAL 206 0.0299
213 TYPE 2 DIABETES MELLITUS 991 0.0294
214 HYPOMANIA 105 0.0285
215 LIVER FUNCTION TEST INCREASED 600 0.0279
216 OXYGEN SATURATION ABNORMAL 77 0.0271
217 LIVER INJURY 665 0.0271
218 OBSTRUCTION 108 0.0270
219 POLYP 176 0.0269
220 ALLERGIC SINUSITIS 23 0.0268
221 IMPAIRED HEALING 876 0.0267
222 ARTERIOSCLEROSIS CORONARY ARTERY 176 0.0265
223 NIGHT SWEATS 846 0.0262
224 OBSTRUCTIVE SLEEP APNOEA SYNDROME 38 0.0260
225 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1355 0.0259
226 SYSTEMIC LUPUS ERYTHEMATOSUS 918 0.0258
227 RECTAL PROLAPSE 31 0.0257
228 PULMONARY FIBROSIS 490 0.0255
229 SNORING 96 0.0254
230 ADVERSE REACTION 333 0.0251
231 EPILEPSY 761 0.0249
232 CARDIAC MURMUR 215 0.0248
233 GAIT INABILITY 818 0.0245
234 ALLERGY TO ANIMAL 26 0.0244
235 EMPHYSEMA 246 0.0244
236 CAROTID ARTERIOSCLEROSIS 25 0.0242
237 CARBON DIOXIDE INCREASED 33 0.0242
238 EOSINOPHILIC PNEUMONIA 76 0.0241
239 CONTRAINDICATED PRODUCT ADMINISTERED 725 0.0239
240 ADJUSTMENT DISORDER 31 0.0238
241 C-REACTIVE PROTEIN INCREASED 868 0.0238
242 PNEUMONIA STREPTOCOCCAL 26 0.0237
243 NORMAL NEWBORN 128 0.0235
244 NASAL SEPTUM DEVIATION 46 0.0235
245 RHEUMATOID FACTOR POSITIVE 135 0.0233
246 PRODUCT DOSE OMISSION ISSUE 6869 0.0233
247 HYPERSENSITIVITY PNEUMONITIS 26 0.0228
248 MYCOBACTERIUM AVIUM COMPLEX INFECTION 60 0.0223
249 HYPERCAPNIA 67 0.0222
250 BRONCHIOLITIS 78 0.0221
251 LUNG INFECTION 344 0.0221
252 FOETAL MALFORMATION 24 0.0221
253 RESPIRATORY TRACT INFECTION 574 0.0220
254 OSTEOARTHRITIS 930 0.0219
255 PULMONARY PAIN 63 0.0216
256 POLYMYALGIA RHEUMATICA 68 0.0214
257 SINUS DISORDER 421 0.0212
258 PSORIATIC ARTHROPATHY 859 0.0211
259 NASAL CONGESTION 1235 0.0210
260 PULMONARY CONGESTION 276 0.0209
261 NEPHRECTOMY 31 0.0209
262 UPPER RESPIRATORY TRACT INFLAMMATION 25 0.0208
263 ATELECTASIS 201 0.0208
264 LOWER RESPIRATORY TRACT CONGESTION 35 0.0206
265 MIDDLE INSOMNIA 382 0.0204
266 TACHYARRHYTHMIA 51 0.0204
267 CORONAVIRUS INFECTION 135 0.0204
268 SYMPTOM RECURRENCE 122 0.0204
269 GASTROOESOPHAGEAL REFLUX DISEASE 1632 0.0203
270 SNEEZING 451 0.0201
271 GRANULOMATOSIS WITH POLYANGIITIS 24 0.0199
272 EXOSTOSIS 181 0.0198
273 RESPIRATORY TRACT CONGESTION 314 0.0197
274 HAEMOPTYSIS 544 0.0195
275 CHEST DISCOMFORT 1994 0.0195
276 EXPOSURE TO SARS-COV-2 33 0.0194
277 INFLAMMATION 995 0.0193
278 ASPIRATION 210 0.0192
279 DYSPNOEA 10717 0.0189
280 PHARYNGEAL ERYTHEMA 40 0.0189
281 BRONCHOSPASM 269 0.0188
282 FEMALE GENITAL TRACT FISTULA 32 0.0187
283 HYPERPHOSPHATAEMIA 40 0.0186
284 COUGH 5147 0.0183
285 BLOOD CHOLESTEROL INCREASED 850 0.0182
286 THROAT CLEARING 68 0.0181
287 VACCINATION FAILURE 30 0.0180
288 DEPRESSIVE SYMPTOM 63 0.0179
289 ACCIDENTAL EXPOSURE TO PRODUCT 1840 0.0178
290 RESPIRATORY DISORDER 526 0.0176
291 TERMINAL INSOMNIA 31 0.0175
292 SINUS CONGESTION 236 0.0175
293 SEASONAL ALLERGY 247 0.0174
294 ARTERIOSCLEROSIS 163 0.0173
295 ILL-DEFINED DISORDER 1049 0.0173
296 AUTOIMMUNE DISORDER 167 0.0171
297 THERAPEUTIC PRODUCT EFFECT DECREASED 759 0.0169
298 NASAL OEDEMA 30 0.0166
299 HYPOVENTILATION 54 0.0166
300 CUSHINGOID 53 0.0165
301 PARANASAL SINUS DISCOMFORT 61 0.0161
302 NODULE 210 0.0161
303 SLEEP DISORDER 1121 0.0159
304 INCREASED UPPER AIRWAY SECRETION 81 0.0158
305 PLATELET COUNT INCREASED 203 0.0156
306 BREAST CANCER STAGE II 127 0.0152
307 VIRAL UPPER RESPIRATORY TRACT INFECTION 72 0.0151
308 INFUSION RELATED REACTION 1001 0.0151
309 ULCER HAEMORRHAGE 102 0.0151
310 RESPIRATORY TRACT INFECTION VIRAL 35 0.0150
311 BLISTER 843 0.0150
312 EMERGENCY CARE 45 0.0148
313 PNEUMONIA 4726 0.0146
314 BLOOD CALCIUM INCREASED 127 0.0145
315 DRUG TOLERANCE 73 0.0144
316 RHINORRHOEA 925 0.0143
317 UPPER RESPIRATORY TRACT INFECTION 661 0.0143
318 SLEEP APNOEA SYNDROME 272 0.0142
319 MUSCULOSKELETAL PAIN 746 0.0142
320 HYPERAEMIA 28 0.0142
321 HYPERVENTILATION 82 0.0141
322 ASPHYXIA 115 0.0141
323 EXERCISE TOLERANCE DECREASED 81 0.0141
324 ISCHAEMIC CARDIOMYOPATHY 43 0.0140
325 PATIENT DISSATISFACTION WITH TREATMENT 27 0.0140
326 ARTHROPATHY 778 0.0140
327 HOSPITALISATION 2124 0.0138
328 AORTIC STENOSIS 48 0.0138
329 ALANINE AMINOTRANSFERASE ABNORMAL 29 0.0137
330 NECK PAIN 756 0.0135
331 EOSINOPHILIC OESOPHAGITIS 37 0.0133
332 NONSPECIFIC REACTION 73 0.0133
333 PAINFUL RESPIRATION 32 0.0133
334 HEPATIC ENZYME INCREASED 903 0.0132
335 PROCTITIS 37 0.0132
336 DRUG-INDUCED LIVER INJURY 409 0.0130
337 LUNG CONSOLIDATION 36 0.0129
338 SKIN FRAGILITY 31 0.0127
339 HEPATITIS 325 0.0127
340 RED BLOOD CELL SEDIMENTATION RATE INCREASED 139 0.0125
341 HYPOXIA 441 0.0125
342 RADICULOPATHY 33 0.0125
343 CHOKING SENSATION 69 0.0125
344 NASOPHARYNGITIS 2296 0.0124
345 DYSPNOEA AT REST 36 0.0124
346 IMPAIRED QUALITY OF LIFE 177 0.0123
347 ORTHOPNOEA 39 0.0122
348 SINUSITIS 1242 0.0121
349 DRY MOUTH 966 0.0119
350 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 202 0.0118
351 ENDOTRACHEAL INTUBATION 33 0.0118
352 MOBILITY DECREASED 844 0.0117
353 LUNG NEOPLASM 50 0.0117
354 SUFFOCATION FEELING 29 0.0117
355 CHOKING 228 0.0117
356 DECREASED ACTIVITY 126 0.0117
357 APHONIA 162 0.0116
358 MATERNAL EXPOSURE DURING PREGNANCY 1019 0.0114
359 WALKING AID USER 75 0.0114
360 SCIATICA 180 0.0113
361 ADRENAL INSUFFICIENCY 137 0.0113
362 GRANULOMA 39 0.0113
363 BRONCHITIS 833 0.0112
364 SUSPECTED COVID-19 37 0.0112
365 DRUG INTOLERANCE 1080 0.0112
366 ADENOCARCINOMA 25 0.0111
367 STOMATITIS 676 0.0111
368 PNEUMONIA BACTERIAL 102 0.0111
369 GENERAL PHYSICAL HEALTH DETERIORATION 1285 0.0111
370 PUSTULAR PSORIASIS 38 0.0111
371 UPPER RESPIRATORY TRACT CONGESTION 32 0.0110
372 INFLUENZA 1221 0.0109
373 HERNIA REPAIR 28 0.0108
374 DRUG TOLERANCE DECREASED 30 0.0107
375 LOWER LIMB FRACTURE 205 0.0107
376 ASPERGILLUS INFECTION 70 0.0107
377 BRONCHITIS CHRONIC 26 0.0106
378 EXPOSURE DURING PREGNANCY 656 0.0105
379 SWELLING 986 0.0105
380 SCOLIOSIS 65 0.0105
381 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 68 0.0105
382 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1885 0.0104
383 ORAL CANDIDIASIS 136 0.0103
384 ILLNESS 1042 0.0101
385 APPETITE DISORDER 67 0.0101
386 MIGRAINE 956 0.0100
387 BLOOD PRESSURE DIASTOLIC INCREASED 46 0.0100
388 CYSTIC FIBROSIS 55 0.0099
389 BACTERIAL INFECTION 185 0.0099
390 BUNDLE BRANCH BLOCK LEFT 42 0.0099
391 INJURY 696 0.0099
392 SARS-COV-2 TEST POSITIVE 130 0.0098
393 UNDERDOSE 715 0.0098
394 RIB FRACTURE 201 0.0098
395 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 48 0.0095
396 QUALITY OF LIFE DECREASED 127 0.0095
397 VIRAL INFECTION 314 0.0094
398 EAR DISORDER 43 0.0094
399 OXYGEN SATURATION DECREASED 527 0.0094
400 DYSPHONIA 545 0.0093
401 EYE PRURITUS 313 0.0093
402 HYPOTHYROIDISM 297 0.0093
403 LUPUS-LIKE SYNDROME 84 0.0093
404 CONDITION AGGRAVATED 2813 0.0092
405 PRODUCT STORAGE ISSUE 35 0.0092
406 RESPIRATORY RATE INCREASED 82 0.0092
407 PSEUDOMONAS INFECTION 79 0.0092
408 OSTEOPOROSIS 377 0.0092
409 SCHIZOPHRENIA 111 0.0091
410 EAR PAIN 177 0.0091
411 ANOSMIA 131 0.0090
412 LACRIMATION INCREASED 273 0.0090
413 VENTRICULAR HYPOKINESIA 29 0.0090
414 DRUG EFFECT LESS THAN EXPECTED 132 0.0089
415 JOINT SWELLING 1073 0.0089
416 PRESCRIBED OVERDOSE 172 0.0089
417 URTICARIA 1486 0.0089
418 SKIN ATROPHY 51 0.0089
419 STRIDOR 26 0.0088
420 DISCOMFORT 534 0.0087
421 BENIGN PROSTATIC HYPERPLASIA 45 0.0087
422 RHEUMATOID ARTHRITIS 987 0.0087
423 EYE INJURY 26 0.0085
424 FRUSTRATION TOLERANCE DECREASED 69 0.0085
425 PERIPHERAL SWELLING 1310 0.0085
426 LUNG INFILTRATION 75 0.0085
427 SKIN LACERATION 92 0.0085
428 PRESCRIBED UNDERDOSE 168 0.0084
429 TREATMENT FAILURE 695 0.0084
430 HYPOPNOEA 29 0.0083
431 DYSPEPSIA 815 0.0083
432 RASH VESICULAR 40 0.0083
433 INTENTIONAL PRODUCT USE ISSUE 723 0.0082
434 IRON DEFICIENCY 37 0.0082
435 PRODUCT DOSE OMISSION 536 0.0082
436 GLAUCOMA 157 0.0081
437 TROPONIN INCREASED 62 0.0081
438 HERPES ZOSTER 464 0.0081
439 HYPOAESTHESIA 1197 0.0080
440 OROPHARYNGEAL PAIN 737 0.0080
441 OROPHARYNGEAL DISCOMFORT 71 0.0079
442 PNEUMONITIS 214 0.0079
443 ARTHRITIS INFECTIVE 36 0.0078
444 CATARACT OPERATION 46 0.0077
445 SKIN LESION 212 0.0077
446 SPONDYLITIS 28 0.0077
447 BLOOD POTASSIUM DECREASED 231 0.0077
448 OCULAR DISCOMFORT 86 0.0077
449 MUSCULOSKELETAL STIFFNESS 671 0.0077
450 INJECTION SITE REACTION 522 0.0076
451 FLANK PAIN 71 0.0076
452 INCORRECT PRODUCT ADMINISTRATION DURATION 164 0.0076
453 GESTATIONAL DIABETES 36 0.0075
454 EAR INFECTION 201 0.0075
455 HYPERTENSION 1597 0.0075
456 PHARYNGITIS 93 0.0075
457 UMBILICAL HERNIA 35 0.0075
458 HIP ARTHROPLASTY 114 0.0074
459 HEPATIC CYST 25 0.0074
460 PNEUMONIA FUNGAL 29 0.0073
461 HIATUS HERNIA 95 0.0073
462 KIDNEY INFECTION 143 0.0073
463 NEAR DEATH EXPERIENCE 24 0.0073
464 GASTROINTESTINAL DISORDER 646 0.0072
465 MUSCULOSKELETAL CHEST PAIN 111 0.0072
466 PRODUCT PREPARATION ISSUE 47 0.0072
467 PAROSMIA 54 0.0071
468 CATARACT 425 0.0071
469 PNEUMOTHORAX 112 0.0071
470 GASTRIC INFECTION 27 0.0071
471 LIMB INJURY 191 0.0070
472 HIP SURGERY 38 0.0070
473 OESOPHAGEAL DISORDER 27 0.0070
474 RESPIRATORY SYNCYTIAL VIRUS INFECTION 61 0.0070
475 LUMBAR VERTEBRAL FRACTURE 32 0.0070
476 INFECTION 1007 0.0070
477 PRODUCT USE IN UNAPPROVED INDICATION 1721 0.0069
478 EYE OPERATION 32 0.0069
479 THERAPY CESSATION 354 0.0069
480 FOOD ALLERGY 53 0.0069
481 MEMORY IMPAIRMENT 931 0.0068
482 LUNG NEOPLASM MALIGNANT 278 0.0068
483 MUSCLE SPASMS 1233 0.0067
484 PARAESTHESIA 1052 0.0067
485 ADVERSE DRUG REACTION 600 0.0067
486 RHINOVIRUS INFECTION 26 0.0067
487 CHOLELITHIASIS 217 0.0066
488 BRONCHOPULMONARY ASPERGILLOSIS 51 0.0066
489 WHEELCHAIR USER 29 0.0065
490 LUNG TRANSPLANT 23 0.0065
491 CONFUSIONAL STATE 1043 0.0064
492 MALAISE 2828 0.0064
493 MATERNAL EXPOSURE TIMING UNSPECIFIED 24 0.0064
494 MUSCULAR WEAKNESS 724 0.0064
495 DISEASE RECURRENCE 303 0.0064
496 HYPERSENSITIVITY 1173 0.0063
497 RENAL CYST 50 0.0063
498 GLUCOSE TOLERANCE IMPAIRED 37 0.0063
499 KNEE ARTHROPLASTY 131 0.0062
500 ODYNOPHAGIA 37 0.0062
501 MYASTHENIA GRAVIS 50 0.0062
502 GASTROENTERITIS 90 0.0062
503 OVERWEIGHT 33 0.0061
504 ANGINA PECTORIS 176 0.0061
505 TOOTH ABSCESS 62 0.0061
506 CONTUSION 585 0.0061
507 CARDIAC PACEMAKER INSERTION 36 0.0060
508 CARDIOMYOPATHY 88 0.0059
509 ABDOMINAL DISCOMFORT 995 0.0059
510 COVID-19 PNEUMONIA 70 0.0059
511 THERAPEUTIC RESPONSE SHORTENED 196 0.0059
512 ORAL INFECTION 23 0.0059
513 PRODUCT ADMINISTRATION ERROR 118 0.0058
514 TRANSAMINASES INCREASED 129 0.0058
515 HEPATIC LESION 25 0.0058
516 IMMUNOSUPPRESSION 51 0.0058
517 IMMUNE SYSTEM DISORDER 76 0.0058
518 ECZEMA 300 0.0057
519 IMMOBILE 25 0.0057
520 JOINT INJURY 122 0.0057
521 DIABETES MELLITUS 435 0.0057
522 BLOOD PRESSURE INCREASED 871 0.0057
523 HYPERLIPIDAEMIA 68 0.0057
524 HYPOPHOSPHATAEMIA 42 0.0057
525 NEURALGIA 138 0.0057
526 LEFT VENTRICULAR DYSFUNCTION 38 0.0057
527 DEVICE USE ERROR 196 0.0056
528 MACULAR DEGENERATION 67 0.0056
529 HEPATIC CIRRHOSIS 105 0.0056
530 JOINT DISLOCATION 59 0.0056
531 ABDOMINAL PAIN UPPER 1148 0.0056
532 GOUT 100 0.0056
533 WEIGHT INCREASED 1247 0.0056
534 OEDEMA PERIPHERAL 677 0.0055
535 HYPERTHYROIDISM 80 0.0055
536 RESPIRATORY DISTRESS 152 0.0055
537 DERMATITIS ALLERGIC 69 0.0055
538 BACK PAIN 1270 0.0055
539 ABDOMINAL TENDERNESS 27 0.0054
540 TRANSIENT ISCHAEMIC ATTACK 183 0.0054
541 HEART RATE INCREASED 536 0.0054
542 CONJUNCTIVITIS 100 0.0054
543 PAIN IN EXTREMITY 1583 0.0054
544 PRODUCT QUALITY ISSUE 725 0.0053
545 SENSITIVITY TO WEATHER CHANGE 28 0.0053
546 SUSPECTED OFF LABEL USE 24 0.0053
547 PARAESTHESIA ORAL 76 0.0053
548 ECCHYMOSIS 36 0.0052
549 ABDOMINAL DISTENSION 548 0.0052
550 MYOSITIS 47 0.0052
551 CARDIAC OPERATION 45 0.0052
552 LIMB OPERATION 25 0.0052
553 HEPATOTOXICITY 116 0.0052
554 STENT PLACEMENT 42 0.0052
555 SCRATCH 54 0.0051
556 LYMPHADENOPATHY 180 0.0051
557 TENDON DISORDER 33 0.0051
558 DEPRESSION 1149 0.0050
559 ROAD TRAFFIC ACCIDENT 211 0.0050
560 ABDOMINAL HERNIA 23 0.0050
561 CONCUSSION 39 0.0050
562 SPINAL OPERATION 62 0.0050
563 CHEST PAIN 928 0.0050
564 SYNOVIAL CYST 23 0.0050
565 HEAD DISCOMFORT 88 0.0050
566 FOOT DEFORMITY 55 0.0050
567 ARTHRALGIA 2048 0.0049
568 BACK DISORDER 80 0.0049
569 PULMONARY OEDEMA 220 0.0049
570 FREQUENT BOWEL MOVEMENTS 132 0.0049
571 KNEE OPERATION 48 0.0049
572 ACCIDENT 58 0.0049
573 HYSTERECTOMY 42 0.0048
574 COVID-19 843 0.0048
575 DISABILITY 95 0.0048
576 PHARYNGEAL SWELLING 47 0.0048
577 NASAL DISCOMFORT 38 0.0048
578 EAR DISCOMFORT 49 0.0048
579 CELLULITIS 240 0.0048
580 INABILITY TO AFFORD MEDICATION 47 0.0047
581 JOINT STIFFNESS 123 0.0047
582 PAPULE 33 0.0047
583 THERAPEUTIC RESPONSE UNEXPECTED 210 0.0047
584 CYSTITIS 149 0.0047
585 THYROID DISORDER 72 0.0047
586 PERIPHERAL VASCULAR DISORDER 24 0.0047
587 ASTHENIA 1746 0.0046
588 ARTHRITIS 365 0.0046
589 MICTURITION URGENCY 53 0.0046
590 FEAR OF INJECTION 33 0.0046
591 SCAB 52 0.0046
592 CHOLECYSTECTOMY 52 0.0045
593 PRODUCT DISTRIBUTION ISSUE 42 0.0045
594 ANAPHYLACTIC REACTION 249 0.0045
595 PYREXIA 1558 0.0045
596 THROAT IRRITATION 201 0.0045
597 POST-TRAUMATIC STRESS DISORDER 30 0.0045
598 PRODUCT USE ISSUE 838 0.0045
599 ALOPECIA 869 0.0044
600 HEADACHE 2774 0.0044
601 PULMONARY EMBOLISM 419 0.0044
602 GENERAL SYMPTOM 33 0.0044
603 DIVERTICULITIS 122 0.0044
604 FALL 1464 0.0044
605 RASH 1912 0.0044
606 THROMBOSIS 347 0.0043
607 ATRIAL FIBRILLATION 420 0.0043
608 PAIN 2618 0.0043
609 BEDRIDDEN 56 0.0043
610 RENAL PAIN 45 0.0042
611 APNOEA 33 0.0042
612 IMMUNODEFICIENCY 63 0.0042
613 INSOMNIA 1110 0.0042
614 BODY TEMPERATURE DECREASED 41 0.0042
615 BLOOD PRESSURE SYSTOLIC INCREASED 81 0.0041
616 FEEDING DISORDER 84 0.0041
617 BLOOD BILIRUBIN INCREASED 111 0.0041
618 THROAT TIGHTNESS 111 0.0041
619 SURGERY 240 0.0041
620 ORAL DISORDER 30 0.0041
621 FATIGUE 3151 0.0040
622 LIGAMENT SPRAIN 40 0.0040
623 PRODUCT AVAILABILITY ISSUE 92 0.0040
624 NERVE COMPRESSION 37 0.0040
625 POOR QUALITY SLEEP 86 0.0040
626 INJECTION SITE DISCOMFORT 42 0.0040
627 DRUG EFFECT INCOMPLETE 145 0.0040
628 ACUTE CORONARY SYNDROME 33 0.0040
629 PEMPHIGOID 30 0.0040
630 BLOOD PRESSURE ABNORMAL 79 0.0040
631 THERAPY NON-RESPONDER 178 0.0040
632 TREATMENT NONCOMPLIANCE 216 0.0039
633 FUNGAL INFECTION 131 0.0039
634 PSYCHOTIC DISORDER 116 0.0039
635 LIVER DISORDER 173 0.0039
636 MUSCULOSKELETAL DISCOMFORT 67 0.0039
637 THERAPEUTIC RESPONSE DECREASED 236 0.0039
638 BLOOD IRON DECREASED 46 0.0039
639 BLOOD DISORDER 31 0.0039
640 PULMONARY THROMBOSIS 42 0.0038
641 EYE DISORDER 126 0.0038
642 LEUKAEMIA 36 0.0038
643 TACHYCARDIA 338 0.0038
644 JOINT EFFUSION 26 0.0038
645 ESCHERICHIA INFECTION 31 0.0038
646 PURPURA 33 0.0037
647 NEPHROLITHIASIS 171 0.0037
648 DIZZINESS 1835 0.0037
649 FEELING HOT 225 0.0037
650 THERAPY INTERRUPTED 259 0.0036
651 SKIN MASS 24 0.0036
652 DRUG INEFFECTIVE 4736 0.0036
653 OFF LABEL USE 3137 0.0036
654 BREAST MASS 24 0.0036
655 VAGINAL DISCHARGE 36 0.0036
656 LOCALISED INFECTION 86 0.0036
657 FACIAL PARALYSIS 30 0.0035
658 DELIRIUM 122 0.0035
659 SKIN DISORDER 117 0.0035
660 OEDEMA 190 0.0035
661 WHITE BLOOD CELL COUNT INCREASED 134 0.0035
662 RECTAL HAEMORRHAGE 150 0.0035
663 CARDIAC DISORDER 326 0.0035
664 INCORRECT DOSE ADMINISTERED 791 0.0035
665 ULCER 55 0.0035
666 EYE INFECTION 39 0.0035
667 INFLUENZA LIKE ILLNESS 284 0.0034
668 SPINAL FRACTURE 69 0.0034
669 WEIGHT FLUCTUATION 36 0.0034
670 HEART RATE IRREGULAR 77 0.0034
671 HEART RATE DECREASED 119 0.0034
672 MYALGIA 575 0.0034
673 CANDIDA INFECTION 57 0.0034
674 ANXIETY 958 0.0034
675 GAIT DISTURBANCE 644 0.0034
676 INFARCTION 23 0.0034
677 PRODUCT STORAGE ERROR 294 0.0034
678 ACUTE RESPIRATORY FAILURE 64 0.0033
679 APPENDICITIS 31 0.0033
680 DEPRESSED MOOD 172 0.0033
681 TACHYPNOEA 44 0.0032
682 RASH PRURITIC 174 0.0032
683 SKIN INFECTION 36 0.0032
684 BLOOD GLUCOSE FLUCTUATION 35 0.0032
685 ADVERSE EVENT 293 0.0032
686 AMNESIA 206 0.0032
687 FOOT FRACTURE 60 0.0032
688 UPPER LIMB FRACTURE 63 0.0032
689 CARDIAC FAILURE CONGESTIVE 254 0.0032
690 DRY THROAT 32 0.0031
691 CYST 39 0.0031
692 PSYCHIATRIC SYMPTOM 23 0.0031
693 HEPATIC STEATOSIS 58 0.0031
694 ABDOMINAL PAIN 723 0.0031
695 RESPIRATORY FAILURE 226 0.0031
696 INJECTION SITE PAIN 943 0.0031
697 HYPOACUSIS 132 0.0031
698 NERVE INJURY 34 0.0031
699 HERNIA 59 0.0030
700 FACIAL PAIN 27 0.0030
701 DECREASED APPETITE 702 0.0030
702 REBOUND EFFECT 34 0.0030
703 PANCREATITIS 159 0.0030
704 LIMB DISCOMFORT 93 0.0030
705 WEIGHT DECREASED 838 0.0030
706 SENSORY DISTURBANCE 48 0.0030
707 LYMPHOMA 46 0.0030
708 HAEMORRHOIDS 58 0.0030
709 EYE SWELLING 109 0.0029
710 OCULAR HYPERAEMIA 139 0.0029
711 FOETAL EXPOSURE DURING PREGNANCY 238 0.0029
712 CARDIOMEGALY 36 0.0029
713 HIP FRACTURE 94 0.0029
714 RASH ERYTHEMATOUS 139 0.0029
715 PLEURAL EFFUSION 176 0.0029
716 MUSCLE STRAIN 25 0.0029
717 VOMITING 1357 0.0029
718 PYELONEPHRITIS 25 0.0029
719 PNEUMONIA ASPIRATION 72 0.0029
720 BRAIN FOG 45 0.0029
721 POST PROCEDURAL COMPLICATION 55 0.0029
722 DECREASED IMMUNE RESPONSIVENESS 28 0.0029
723 INJECTION SITE URTICARIA 70 0.0029
724 URINARY RETENTION 95 0.0028
725 CORONARY ARTERY DISEASE 86 0.0028
726 BLOOD PRESSURE DECREASED 187 0.0028
727 COLITIS ULCERATIVE 125 0.0028
728 BODY TEMPERATURE INCREASED 57 0.0028
729 INTERVERTEBRAL DISC PROTRUSION 61 0.0028
730 BLOOD URINE PRESENT 52 0.0027
731 GROIN PAIN 24 0.0027
732 BRAIN NEOPLASM 25 0.0027
733 PRODUCT PRESCRIBING ISSUE 59 0.0027
734 CHILLS 316 0.0027
735 BURNING SENSATION 189 0.0027
736 PRODUCT DOSE OMISSION IN ERROR 76 0.0027
737 BLOOD PRESSURE FLUCTUATION 64 0.0027
738 TOOTH INFECTION 35 0.0027
739 ACUTE MYOCARDIAL INFARCTION 78 0.0026
740 PRODUCT PREPARATION ERROR 54 0.0026
741 INSURANCE ISSUE 40 0.0026
742 SPEECH DISORDER 136 0.0026
743 VERTIGO 158 0.0026
744 SWELLING FACE 167 0.0026
745 NEOPLASM MALIGNANT 171 0.0026
746 SKIN CANCER 55 0.0026
747 URINARY INCONTINENCE 75 0.0025
748 HOSPICE CARE 25 0.0025
749 MYOCARDITIS 29 0.0025
750 DEAFNESS 66 0.0025
751 BLADDER DISORDER 25 0.0025
752 HAEMATOMA 65 0.0025
753 LABORATORY TEST ABNORMAL 74 0.0025
754 COLITIS 95 0.0025
755 WRIST FRACTURE 30 0.0025
756 SYNCOPE 250 0.0025
757 SWOLLEN TONGUE 78 0.0025
758 TOOTH EXTRACTION 31 0.0025
759 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 84 0.0025
760 AGEUSIA 62 0.0025
761 COLON CANCER 37 0.0025
762 INJECTION SITE RASH 76 0.0025
763 OESOPHAGITIS 27 0.0025
764 PALPITATIONS 288 0.0025
765 ARRHYTHMIA 116 0.0024
766 TREMOR 406 0.0024
767 GASTROENTERITIS VIRAL 44 0.0024
768 BASAL CELL CARCINOMA 38 0.0024
769 HEAD INJURY 77 0.0024
770 PRURITUS 933 0.0024
771 ANKLE FRACTURE 37 0.0024
772 DERMATITIS 50 0.0024
773 INTENTIONAL DOSE OMISSION 68 0.0024
774 FLUID RETENTION 121 0.0024
775 URINARY TRACT INFECTION 403 0.0024
776 ACCIDENTAL UNDERDOSE 34 0.0024
777 ORAL HERPES 46 0.0024
778 PRODUCT DISPENSING ERROR 51 0.0023
779 BLINDNESS UNILATERAL 33 0.0023
780 VISUAL IMPAIRMENT 288 0.0023
781 OSTEOPENIA 35 0.0023
782 SPINAL PAIN 27 0.0023
783 INJECTION SITE SWELLING 175 0.0023
784 COLD SWEAT 40 0.0023
785 THYROID CANCER 27 0.0022
786 HYPERSOMNIA 64 0.0022
787 DEMENTIA 62 0.0022
788 NEUROPATHY PERIPHERAL 211 0.0022
789 PHARYNGITIS STREPTOCOCCAL 24 0.0022
790 INCORRECT DOSE ADMINISTERED BY DEVICE 58 0.0022
791 RETCHING 47 0.0022
792 PROCEDURAL PAIN 61 0.0022
793 END STAGE RENAL DISEASE 40 0.0022
794 BLOOD CREATININE INCREASED 143 0.0022
795 MOVEMENT DISORDER 70 0.0022
796 PHOTOPHOBIA 41 0.0022
797 DEATH 1863 0.0022
798 DIARRHOEA 1395 0.0022
799 INJECTION SITE PRURITUS 143 0.0021
800 DYSPHAGIA 202 0.0021
801 PRURITUS GENERALISED 46 0.0021
802 SINUS TACHYCARDIA 30 0.0021
803 DERMATITIS CONTACT 24 0.0021
804 BONE PAIN 123 0.0021
805 LOSS OF CONSCIOUSNESS 269 0.0021
806 ANAPHYLACTIC SHOCK 54 0.0021
807 STAPHYLOCOCCAL INFECTION 69 0.0021
808 MALIGNANT MELANOMA 28 0.0021
809 RENAL DISORDER 97 0.0021
810 NAUSEA 1632 0.0021
811 ERYTHEMA 423 0.0021
812 DYSSTASIA 60 0.0021
813 TOOTHACHE 37 0.0020
814 CYANOSIS 32 0.0020
815 INJECTION SITE BRUISING 162 0.0020
816 METASTASES TO CENTRAL NERVOUS SYSTEM 26 0.0020
817 MULTIPLE ORGAN DYSFUNCTION SYNDROME 57 0.0020
818 MASS 28 0.0020
819 LYMPHOPENIA 28 0.0020
820 NOCTURIA 24 0.0020
821 DYSURIA 72 0.0020
822 SMALL INTESTINAL OBSTRUCTION 24 0.0019
823 FEELING ABNORMAL 461 0.0019
824 HAEMATOCHEZIA 106 0.0019
825 RASH MACULAR 67 0.0019
826 MYOCARDIAL INFARCTION 334 0.0019
827 CEREBROVASCULAR ACCIDENT 322 0.0019
828 SKIN DISCOLOURATION 87 0.0019
829 MUSCULOSKELETAL DISORDER 36 0.0019
830 PALLOR 51 0.0019
831 EYE HAEMORRHAGE 25 0.0019
832 DIABETES MELLITUS INADEQUATE CONTROL 33 0.0019
833 PERICARDIAL EFFUSION 43 0.0019
834 INTERSTITIAL LUNG DISEASE 90 0.0019
835 SEPSIS 207 0.0019
836 INJECTION SITE HAEMORRHAGE 148 0.0019
837 CARDIOVASCULAR DISORDER 47 0.0018
838 DIPLOPIA 48 0.0018
839 PREGNANCY 37 0.0018
840 FACE OEDEMA 31 0.0018
841 NERVOUSNESS 96 0.0018
842 FEELING COLD 51 0.0018
843 DERMATITIS ATOPIC 96 0.0018
844 ANAEMIA 342 0.0018
845 INJECTION SITE HAEMATOMA 26 0.0018
846 ROTATOR CUFF SYNDROME 23 0.0018
847 PRODUCT PRESCRIBING ERROR 42 0.0018
848 SCAR 30 0.0018
849 VISION BLURRED 240 0.0017
850 FRACTURE 33 0.0017
851 HAEMORRHAGE 180 0.0017
852 CARDIAC FAILURE 138 0.0017
853 RENAL IMPAIRMENT 139 0.0017
854 LIP SWELLING 55 0.0016
855 HYPERGLYCAEMIA 60 0.0016
856 EPISTAXIS 122 0.0016
857 MEDICATION ERROR 90 0.0016
858 OSTEOMYELITIS 29 0.0016
859 DEVICE USE ISSUE 28 0.0016
860 EMOTIONAL DISTRESS 193 0.0016
861 SOMNOLENCE 320 0.0016
862 INJECTION SITE ERYTHEMA 196 0.0016
863 MOUTH ULCERATION 33 0.0016
864 RESTLESS LEGS SYNDROME 28 0.0015
865 HYPERHIDROSIS 198 0.0015
866 HYPOTENSION 308 0.0015
867 INTESTINAL OBSTRUCTION 57 0.0015
868 CLOSTRIDIUM DIFFICILE INFECTION 33 0.0015
869 POLLAKIURIA 63 0.0015
870 RASH GENERALISED 39 0.0015
871 SKIN EXFOLIATION 127 0.0015
872 BALANCE DISORDER 129 0.0015
873 TENDONITIS 23 0.0015
874 MUSCLE TIGHTNESS 24 0.0015
875 EXTRA DOSE ADMINISTERED 60 0.0015
876 DEEP VEIN THROMBOSIS 96 0.0015
877 CONSTIPATION 322 0.0015
878 DRUG DOSE OMISSION 244 0.0015
879 RASH PAPULAR 33 0.0015
880 FLATULENCE 83 0.0015
881 ISCHAEMIC STROKE 26 0.0015
882 GALLBLADDER DISORDER 26 0.0015
883 AGGRESSION 72 0.0014
884 RED BLOOD CELL COUNT DECREASED 41 0.0014
885 GASTRIC ULCER 27 0.0014
886 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 41 0.0014
887 HYPONATRAEMIA 78 0.0014
888 DYSARTHRIA 52 0.0014
889 ANGIOEDEMA 61 0.0014
890 HAEMATURIA 47 0.0014
891 BONE DISORDER 25 0.0014
892 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 25 0.0014
893 MENTAL DISORDER 59 0.0014
894 PROSTATE CANCER 109 0.0014
895 DRUG DEPENDENCE 217 0.0013
896 OVERDOSE 291 0.0013
897 FAECES DISCOLOURED 29 0.0013
898 ASCITES 39 0.0013
899 APHASIA 40 0.0013
900 FEMUR FRACTURE 41 0.0013
901 EATING DISORDER 28 0.0013
902 INJECTION SITE WARMTH 27 0.0013
903 FEAR 35 0.0013
904 DRUG EFFECT DECREASED 70 0.0013
905 THIRST 23 0.0013
906 GASTRIC DISORDER 44 0.0013
907 SEIZURE 147 0.0013
908 DRY SKIN 169 0.0013
909 BLOOD GLUCOSE ABNORMAL 23 0.0012
910 PANIC ATTACK 45 0.0012
911 ABDOMINAL PAIN LOWER 31 0.0012
912 ABORTION SPONTANEOUS 48 0.0012
913 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 65 0.0012
914 DRY EYE 59 0.0012
915 HOT FLUSH 89 0.0012
916 COGNITIVE DISORDER 55 0.0012
917 BREAST CANCER 109 0.0012
918 OSTEONECROSIS 38 0.0012
919 MOOD SWINGS 36 0.0011
920 CARDIAC ARREST 93 0.0011
921 IMPAIRED WORK ABILITY 24 0.0011
922 PANCREATIC CARCINOMA 32 0.0011
923 HALLUCINATION 82 0.0011
924 SEPTIC SHOCK 47 0.0011
925 BLINDNESS 44 0.0011
926 INTENTIONAL PRODUCT MISUSE 94 0.0011
927 HAEMATEMESIS 27 0.0011
928 CEREBRAL INFARCTION 26 0.0011
929 HYPOKALAEMIA 48 0.0010
930 RENAL FAILURE 137 0.0010
931 NERVOUS SYSTEM DISORDER 32 0.0010
932 HYPOPHAGIA 26 0.0010
933 RESPIRATORY ARREST 28 0.0010
934 SKIN ULCER 26 0.0010
935 FLUSHING 102 0.0010
936 PSORIASIS 131 0.0010
937 MUSCLE TWITCHING 23 0.0010
938 LETHARGY 57 0.0010
939 DEHYDRATION 131 0.0010
940 EYE PAIN 55 0.0010
941 EMOTIONAL DISORDER 30 0.0010
942 HAEMOGLOBIN DECREASED 99 0.0010
943 GLYCOSYLATED HAEMOGLOBIN INCREASED 24 0.0009
944 PRESYNCOPE 23 0.0009
945 CRYING 34 0.0009
946 MULTIPLE SCLEROSIS 44 0.0009
947 INJECTION SITE MASS 34 0.0009
948 TINNITUS 42 0.0009
949 GASTRITIS 24 0.0009
950 BREAST CANCER FEMALE 24 0.0009
951 IRRITABILITY 54 0.0009
952 NEEDLE ISSUE 26 0.0009
953 NO ADVERSE EVENT 158 0.0009
954 AGITATION 64 0.0009
955 EYE IRRITATION 50 0.0009
956 SUICIDAL IDEATION 79 0.0009
957 DYSGEUSIA 64 0.0009
958 COMA 41 0.0009
959 PAIN IN JAW 24 0.0008
960 ACCIDENTAL OVERDOSE 30 0.0008
961 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 57 0.0008
962 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 161 0.0008
963 DISORIENTATION 31 0.0008
964 CHRONIC KIDNEY DISEASE 58 0.0008
965 NEUTROPHIL COUNT DECREASED 29 0.0007
966 UNEVALUABLE EVENT 53 0.0007
967 DEVICE LEAKAGE 30 0.0007
968 BLOOD GLUCOSE DECREASED 33 0.0007
969 DISTURBANCE IN ATTENTION 36 0.0007
970 SKIN BURNING SENSATION 47 0.0007
971 DEVICE MALFUNCTION 46 0.0007
972 BLOOD GLUCOSE INCREASED 122 0.0006
973 DISEASE PROGRESSION 74 0.0006
974 BRADYCARDIA 31 0.0006
975 SKIN IRRITATION 24 0.0005
976 LEUKOPENIA 25 0.0005
977 HYPOGLYCAEMIA 23 0.0005
978 GASTROINTESTINAL HAEMORRHAGE 39 0.0005
979 ACNE 34 0.0004
980 DEVICE ISSUE 35 0.0004
981 WHITE BLOOD CELL COUNT DECREASED 41 0.0004
982 THROMBOCYTOPENIA 35 0.0003
983 DRUG ABUSE 26 0.0003
984 DRUG DOSE OMISSION BY DEVICE 24 0.0003
985 ACUTE KIDNEY INJURY 45 0.0003
986 PLATELET COUNT DECREASED 24 0.0002
987 DRUG INTERACTION 33 0.0002
988 NEUTROPENIA 27 0.0002
989 TOXICITY TO VARIOUS AGENTS 23 0.0001